Detalles de la búsqueda
1.
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Gastric Cancer
; 25(4): 783-793, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352176
2.
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 36(1): 85-95, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28726132
3.
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy.
Haematologica
; 100(7): 898-904, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887498
4.
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
J Natl Cancer Inst
; 108(1)2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26563355
Resultados
1 -
4
de 4
1
Próxima >
>>